STIFEL FINANCIAL CORP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,801
-17.5%
12,329
-5.4%
0.00%
Q2 2023$5,820
-48.1%
13,029
-4.7%
0.00%
Q1 2023$11,212
-49.1%
13,673
-3.2%
0.00%
Q4 2022$22,041
-60.6%
14,129
-56.7%
0.00%
Q3 2022$56,000
+5.7%
32,629
+6.3%
0.00%
Q2 2022$53,000
-51.4%
30,696
+1.0%
0.00%
Q1 2022$109,000
-27.8%
30,3960.0%0.00%
Q4 2021$151,000
-41.2%
30,396
-15.3%
0.00%
Q3 2021$257,000
-7.2%
35,896
+20.4%
0.00%
Q2 2021$277,000
-51.2%
29,806
-51.3%
0.00%
-100.0%
Q1 2021$568,000
+16.6%
61,171
+11.1%
0.00%0.0%
Q4 2020$487,000
-37.8%
55,037
-18.5%
0.00%
-50.0%
Q3 2020$783,000
+86.0%
67,524
+332.0%
0.00%
+100.0%
Q2 2020$421,000
+446.8%
15,630
+51.1%
0.00%
Q1 2020$77,000
-25.2%
10,347
-1.2%
0.00%
-100.0%
Q3 2014$103,000
-33.5%
10,475
-27.0%
0.00%0.0%
Q2 2014$155,00014,3500.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders